APA (7th ed.) Citation

JS, N., AR, L., F, V., B, P., G, F., LM, R., . . . JP, F. (2026). Outcomes With Finerenone by Baseline Treatment Goals in Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis. Diabetes, obesity & metabolism, 28(7), 6022. https://doi.org/10.1111/dom.70750

Chicago Style (17th ed.) Citation

JS, Neves, et al. "Outcomes With Finerenone by Baseline Treatment Goals in Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis." Diabetes, Obesity & Metabolism 28, no. 7 (2026): 6022. https://doi.org/10.1111/dom.70750.

MLA (9th ed.) Citation

JS, Neves, et al. "Outcomes With Finerenone by Baseline Treatment Goals in Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis." Diabetes, Obesity & Metabolism, vol. 28, no. 7, 2026, p. 6022, https://doi.org/10.1111/dom.70750.